Unlocking Q4 Potential of Hologic (HOLX): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Hologic (HOLX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key met...
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest trading session, Hologic (HOLX) closed at $80.46, marking a -0.46% move from the previous day.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Hologic (HOLX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw Hologic (HOLX) settling at $81.15, representing a -0.51% change from its previous close.
Should You Buy, Sell or Hold HOLX Stock Ahead of Q4 Earnings?
Hologic's upcoming fourth-quarter fiscal 2024 financial report is expected to reflect strength in core franchises.
Hologic to acquire Gynesonics in $350M deal to boost Fibroid treatments
Hologic Inc. President and CEO Steve MacMillan joins ‘Mornings with Maria' to discuss his company's latest technological strides in women's health.
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should You Bet on HOLX Stock This Breast Cancer Awareness Month?
October is celebrated as breast cancer awareness month annually, and Hologic HOLX, this time too, honored the occasion by ringing the Nasdaq opening bell for the 18th consecutive time. While celebr...
Hologic (HOLX) Stock Sinks As Market Gains: Here's Why
Hologic (HOLX) reachead $79.77 at the closing of the latest trading day, reflecting a -0.98% change compared to its last close.
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #bcam--Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month.
Is HOLX Stock a Smart Hold for Your Portfolio Right Now?
Hologic's strength in Molecular Diagnostics is highly promising. Yet, macroeconomic uncertainties can pose headwinds for its operations.
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Hologic (HOLX) Q3 Earnings and Revenues Top Estimates
Hologic (HOLX) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.93 per share a year ago.
HOLX or SONVY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a...
72 Million American Women Have Skipped or Delayed Vital Screenings
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #HGWHI--72 Million American Women Have Skipped or Delayed Vital Screenings.
Related Companies